Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Czechia / NCT07509489
Recruiting Not applicable

Comparing Game-Based Reward Systems to Support Children's Engagement:

NCT07509489 · tracked via the Priya Life Science Czechia tracker
Phase
Not applicable
Started
2026-03-28
Last updated
2026-05-08

Condition(s) studied

Children

Investigational drug(s) / intervention(s)

Streak-basedLevel-basedCombined: level and streakControl

Streak-based: Participants use a mobile application with gamification elements. Daily completion of target behaviors maintains engagement streaks. Longer streaks unlock virtual items and higher-value financial rewards.

Level-based: Participants use a mobile application that incorporates gamification elements. Completing target behaviors within the app earns points, which contribute to progression through predefined levels. Advancement to higher levels results in higher financial rewards.

Combined: level and streak: Participants use a mobile application with gamification elements. Points earned from completing target behaviors contribute to level progression, while consecutive daily engagement unlocks streak-based rewards. Both mechanisms operate simultaneously to provide financial incentives for achievement and consistency.

Control: Participants use a mobile application that includes gamification elements (e.g., points, levels, or streak indicators) as part of the user interface. However, these in-app gamification features are not financially incentivized. Monetary rewards are determined by questionnaire compliance.

Study summary

This Randomized Control Trial evaluates the impact of different gamification-based incentive schemes (levels, streaks and their combination) on adherence to target behaviors in children. Participants are randomized into four groups with different types of motivational frameworks.

Eligibility

Sex
ALL
Min age
9 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: Children aged 9-12 years Regular smartphone use (at least 4 days per week) Has access to a smartphone throughout most of the day Brings a smartphone to school Owns a personal smartphone with a touchscreen Owns a smartphone with Android operating system (version 9 or higher) Has access to mobile internet on their device Is allowed to use a smartphone at school during breaks (e.g., lunch or longer breaks) for questionnaire completion and to wear a smartwatch Native Czech speaker Exclusion Criteria: Does not meet one or more of the inclusion criteria Has a sibling already enrolled in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Palacky University Olomouc Czechia Recruiting

More Palacky University trials in Czechia

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07509489 on ClinicalTrials.gov ↗ ← All trials in Czechia